Gregory B. Haber

Title: MD
Position: Professor of Medicine and Biochemistry and Molecular Pharmacology | Chief of Endoscopy, NYU Langone Health | Director of the Center for Advanced Therapeutics and Innovation
Organization: NYU Langone Health, New York, NY
Country: USA
Dr. Haber is one of the world’s foremost experts in clinical care and education in advanced therapeutic endoscopy. Dr. Haber has dedicated himself to the mentorship of the next generation of physicians in these techniques and technologies, having trained more than 60 advanced fellows. Dr Haber introduced the Live Endoscopy program to the New York Society in 2005 and had been a director for this program for the past 20 years.

After receiving his medical degree from the University of Toronto, Dr. Haber completed his training in Internal Medicine and Gastroenterology. He subsequently received a Medical Research Council of Canada Grant to do postgraduate research in bile acid metabolism at the Bristol Royal Infirmary, Bristol, England. He returned to the University of Toronto as a consultant at The Wellesley Hospital and St. Michael’s Hospital where the Advanced Endoscopy Center for the University was established. He was appointed Chief of Gastroenterology at Lenox Hill Hospital from 2004 to 2016. He then moved to NYU to become system Chief of Advanced Endoscopy and Director of the Center for Advanced Therapeutics and Innovation, a position he held from 2016-2026. Dr Haber recently accepted a leadership role at White Plains Hospital, a Montefiore affiliate, to develop a tertiary care Advanced Therapeutic Endoscopy Program.

Dr. Haber has contributed over 100 scientific publications, over 200 abstracts, and more than 400 presentations at educational seminars and conferences nationally and internationally. He frequently serves as a course director for educational conferences and in 2010 was the recipient of the American Society for Gastrointestinal Endoscopy’s Master of Endoscopy Award.

In 2018, Dr. Haber was honored with the title of Professor of Medicine and Biochemistry and Molecular Pharmacology by NYU, New York. In 2025 Dr Haber received the Schindler Award from the American Society of Gastrointestinal Endoscopy, the highest reward of the society given annually to an individual who has made outstanding contributions to Endoscopy.

His areas of expertise include Advanced Resection with ESD, EMR, and Full Thickness Resection, Third space intervention with POEM for achalasia, gastroparesis, and Zenker’s. He has also had a lifelong commitment to pancreatico-biliary disease with ERCP and EUS interventions, including EUS access techniques and ablation.